Loading viewer...
investor_presentation
Format: PDF investor_presentation
Marksans Pharma Limited presents Q4 and full-year FY23 financial results and strategic overview for creating a global pharmaceutical company. The presentation covers key business highlights, organizational strengths, global market expansion plans, and five-year outlook targets.
investor_presentation
Kazia Therapeutics
Silver Viper Minerals Corp. Presentation June 2024
investor_presentationinvestor_presentation
28 Pages
Silver Viper Minerals Corp.